top of page
laptop and phone on a white desk but zoom in on phone and laptop with the word news on the
Search

KRTL Holding Group Announces Court Order Approving Further Cancellation and Correction of Legacy Shares and Establishing Corporate Baseline

  • KRTL Holding
  • 5 days ago
  • 4 min read

KRTL Holding Group Inc. (OTC: KRTL) (the “Company” or “KRTL”), a diversified holding company with interests in biotech, agriculture, and emerging markets, announced that on January 2, 2026, the Third Judicial District Court of Salt Lake County, Utah, granted the Company’s Verified Motion to approve further cancellation and correction in relation to common stock listings. The Court’s order authorizes the cancellation and correction of 1,330,035 legacy shares of the Company’s common stock that, based on available records and the Company’s shareholder verification procedures, were determined to be unverified, unsubstantiated, or improperly issued.  As of January 5, 2026, the Company’s transfer agent reports 98,016,072 shares of common stock outstanding; upon implementation of the court-authorized cancellations, the Company expects the reported outstanding share count to be reduced by 1,330,035 shares to 96,686,037 shares.


In its order, the Court addressed the Company’s efforts to restore the availability of accurate, reliable, and current public information. The Court found that the Company has completed PCAOB-audited financial statements as a good-faith effort to provide transparency and reliable information for shareholders and regulatory stakeholders. The Court further found that the Company has cancelled known unverified, unsubstantiated, or improperly issued shares, including 1,330,035 shares addressed by the motion, and that the Company’s current share structure accurately reflects validly issued and outstanding securities. The Court also found and ordered that the Company’s certified, current disclosures, including its PCAOB-audited financial statements and corrected share ledger filed as exhibits with the Court, shall serve as the Company’s official financial and corporate baseline going forward, including for purposes related to SEC Rule 15c2-11 review.


SEC Rule 15c2-11 generally governs the ability of broker-dealers to publish or submit quotations in the OTC market and requires, subject to exceptions, that certain current and publicly available issuer information be reviewed in connection with initiating or resuming quotations. The Company believes the Court’s baseline determination supports the reliability and consistency of the issuer information it makes publicly available in that context.

 

“This court order reinforces our commitment to transparency and responsible corporate governance,” said Cesar Herrera, Chief Executive Officer of KRTL. “It provides additional legal clarity to our share records and recognizes the Company’s current disclosures, including PCAOB-audited financial statements, as an official baseline for purposes related to broker-dealer information review under Rule 15c2-11. Our priority remains the long-term interests of our shareholders.”


This outcome builds on the Company’s previously disclosed shareholder verification initiative first announced on June 4, 2025. Investors can find prior updates in the Company’s public disclosures and press release archive on its website, and at the following link: KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative.


The Company believes that maintaining accurate corporate records and current public disclosures supports investor understanding and enhances the Company’s ability to engage with stakeholders, counterparties, and potential partners. Any statements regarding future quotation eligibility, market status, or exchange listing objectives are forward-looking and subject to risks and uncertainties.

 

About KRTL Holding Group Inc.


KRTL Holding Group Inc. (OTC: KRTL) operates through its subsidiaries KRTL Biotech, Inc. and KRTL International Corp. The Company leverages strategic synergies across biotech, technology, and emerging markets to drive growth and deliver shareholder value.

 

For more information:


 

Forward-Looking Statements

This press release contains statements and information that, to the extent that they are not historical fact, may constitute “forward-looking statements” within the meaning of applicable securities legislation. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to differ materially from any future results, performance, or achievements expressed or implied by these forward-looking statements. Words such as “anticipates,” “will,” “believes,” “plans,” “expects,” “intends,” “projects,” “estimates,” “future,” and “opportunity” and similar expressions are used to identify these forward-looking statements. Forward-looking statements are not guarantees of future performance. Examples of such statements include, but are not limited to, statements with respect to the objectives and business plans of the Company; ability to realize benefits from its recent corporate appointments and acquisitions; ability to retain its key personnel; the intention to grow the Company’s business and operations; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company. Forward-looking information is based on the assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all, as well as all of the other risks. Accordingly, readers should not place undue reliance on any such forward-looking information. Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law.

 
 
 
bottom of page